EFSD, Merck Sharp & Dohme (MSD): Novel Therapies for Type 2 Diabetes
Name: |
EFSD, Merck Sharp & Dohme (MSD): Novel Therapies for Type 2 Diabetes Application deadline: 15/06/15 |
---|---|
General description: |
Intended to fund preclinical/translational research on novel therapies to encourage the identification of new targets for the treatment of type 2 diabetes. Proposals may include but are not limited to:
|
Source: | Foreign |
Budget: | €100,000 |
Contact person: | Robi, 2152, robertg@trdf.technion.ac.il; Michal, 1745, michall@trdf.technion.ac.il |
Fields: | Life Sciences and medicine |
Type of fund: | The fund is not a competitive fund |
Related fund and profiles: | European Foundation for the Study of Diabetes - EFSD ,Access available for Technion staff. Please sign in to see the Agency profiles (upper left corner) |